Controlled release drug delivery systems have transformed the pharmaceutical landscape by offering sustained therapeutic action and improved patient compliance. These ...

The controlled release drug delivery market is poised for growth driven by increased R&D, technological advances, and demand ...

Patient-centric drug development is a concept that has proven to be divisive: Some see it as nothing but a buzzword, while others have embraced the concept completely. Either way, it has garnered much ...

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...

(Nanowerk Spotlight) Precision in drug delivery has long posed a significant challenge to the medical field. Relying on the body’s circulatory system to transport medications often results in ...

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

How can a drug be released or activated exactly where and when it is needed in the body? For many treatments, particularly in cancer therapy, the active compound should ideally act only at a specific ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.